Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 14

    1.

    MicroRNAs: toward the clinic for breast cancer patients.

    Ferracin M, Querzoli P, Calin GA, Negrini M.

    Semin Oncol. 2011 Dec;38(6):764-75. Review.

    PMID:
    22082762
    [PubMed - indexed for MEDLINE]
    2.

    BRCA1 and BRCA2 variants of uncertain significance. Part two: medical management.

    Miller-Samuel S, Rosenberg A, Berger A, Gomella L, Loren D, Morris GJ.

    Semin Oncol. 2011 Oct;38(5):605-11. doi: 10.1053/j.seminoncol.2011.04.009. No abstract available.

    PMID:
    21943665
    [PubMed - indexed for MEDLINE]
    3.

    Variants of uncertain significance in breast cancer-related genes: real-world implications for a clinical conundrum. Part one: clinical genetics recommendations.

    Miller-Samuel S, MacDonald DJ, Weitzel JN, Santiago F, Martino MA, Namey T, Augustyn A, Mueller R, Forman A, Bradbury AR, Morris GJ.

    Semin Oncol. 2011 Aug;38(4):469-80. Review. No abstract available. Erratum in: Semin Oncol. 2012 Feb;39(1):123. McDonald, Deborah J [corrected to MacDonald, Deborah J].

    PMID:
    21810505
    [PubMed - indexed for MEDLINE]
    4.

    Nonpharmacologic complementary therapies in symptom management for breast cancer survivors.

    Blaes AH, Kreitzer MJ, Torkelson C, Haddad T.

    Semin Oncol. 2011 Jun;38(3):394-402. Review.

    PMID:
    21600369
    [PubMed - indexed for MEDLINE]
    5.

    Approved agents for metastatic breast cancer.

    Fornier MN.

    Semin Oncol. 2011 Jun;38 Suppl 2:S3-10. Review.

    PMID:
    21600382
    [PubMed - indexed for MEDLINE]
    6.

    Novel agents and future directions for refractory breast cancer.

    Burstein HJ.

    Semin Oncol. 2011 Jun;38 Suppl 2:S17-24. Review.

    PMID:
    21600381
    [PubMed - indexed for MEDLINE]
    7.

    Other options in the treatment of advanced breast cancer.

    Cobleigh MA.

    Semin Oncol. 2011 Jun;38 Suppl 2:S11-6. Review.

    PMID:
    21600380
    [PubMed - indexed for MEDLINE]
    8.

    Introduction: Current and future approaches to chemotherapy in patients with resistant breast cancer.

    Burstein HJ.

    Semin Oncol. 2011 Jun;38 Suppl 2:S1-2. No abstract available.

    PMID:
    21600379
    [PubMed - indexed for MEDLINE]
    9.

    An update on cancer- and chemotherapy-related cognitive dysfunction: current status.

    Janelsins MC, Kohli S, Mohile SG, Usuki K, Ahles TA, Morrow GR.

    Semin Oncol. 2011 Jun;38(3):431-8. Review.

    PMID:
    21600374
    [PubMed - indexed for MEDLINE]
    10.

    "Targeting" triple-negative breast cancer: the lessons learned from BRCA1-associated breast cancers.

    Nanda R.

    Semin Oncol. 2011 Apr;38(2):254-62. Review.

    PMID:
    21421115
    [PubMed - indexed for MEDLINE]
    11.

    CYP2D6 genotyping and tamoxifen: an unfinished story in the quest for personalized medicine.

    de Souza JA, Olopade OI.

    Semin Oncol. 2011 Apr;38(2):263-73. Review.

    PMID:
    21421116
    [PubMed - indexed for MEDLINE]
    12.

    On the frontline of screening for breast cancer.

    D'Orsi CJ, Newell MS.

    Semin Oncol. 2011 Feb;38(1):119-27. Review.

    PMID:
    21362520
    [PubMed - indexed for MEDLINE]
    13.

    Quantitative ultrasound in cancer imaging.

    Feleppa EJ, Mamou J, Porter CR, Machi J.

    Semin Oncol. 2011 Feb;38(1):136-50.

    PMID:
    21362522
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    Current and future clinical applications for optical imaging of cancer: from intraoperative surgical guidance to cancer screening.

    Hadjipanayis CG, Jiang H, Roberts DW, Yang L.

    Semin Oncol. 2011 Feb;38(1):109-18.

    PMID:
    21362519
    [PubMed - indexed for MEDLINE]
    Free PMC Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk